AI drug development startup Pathos AI closes $237M investment

SiliconANGLEOctober 23, 2026en

Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers. Pathos’ investor roster includes big names such as AstraZeneca plc, NEA and General Atlantic. Pathos is developing cancer drugs […] The post AI drug development startup Pathos AI closes $237M investment appeared first on SiliconANGLE .

This is a short summary published by AI Global Wire. The full article is owned and hosted by SiliconANGLE — open it there to read it in full.

• Verktyg
• Företag